Daito Pharmaceutical Co.,Ltd.

Tokyo Stock Exchange 4577.T

Daito Pharmaceutical Co.,Ltd. Dividend Yield on January 14, 2025: 2.92%

Daito Pharmaceutical Co.,Ltd. Dividend Yield is 2.92% on January 14, 2025, a -8.53% change year over year. Dividend yield measures the dividend per share relative to stock's price value; higher yield suggests higher dividend return.

Daito Pharmaceutical Co.,Ltd. 52-week high Dividend Yield is 3.34% on January 17, 2024, which is 14.53% above the current Dividend Yield.
Daito Pharmaceutical Co.,Ltd. 52-week low Dividend Yield is 2.18% on August 27, 2024, which is -25.43% below the current Dividend Yield.
Daito Pharmaceutical Co.,Ltd. average Dividend Yield for the last 52 weeks is 2.69%.

Key data

Date	Dividend Yield	Free Cash Flow Yield	Earnings Yield	Enterprise Value (EV)

Tokyo Stock Exchange: 4577.T

Daito Pharmaceutical Co.,Ltd.

CEO	Hiroshi Matsumori
IPO Date	March 24, 2010
Location	Japan
Headquarters	326, Yokamachi
Employees	1,070
Sector	Health Care
Industries Pharmaceuticals Consumer Packaged Goods

Description

Daito Pharmaceutical Co.,Ltd. manufactures and sells pharmaceutical products worldwide. The company offers various active pharmaceutical ingredients and intermediates, prescription drugs, OTC drugs, and home-delivery medicines; formulations in various forms, such as tablets, capsules, troches, granules, and powders; and contract manufacturing services for formulations of medicinal products to pharmaceutical companies. It also sells health food products. The company was formerly known as Daito Corporation and changed its name to Daito Pharmaceutical Co.,Ltd. in 1992. Daito Pharmaceutical Co.,Ltd. was incorporated in 1942 and is headquartered in Toyama, Japan.

Key trends

Past 5 years